•Sweden's Videberg Kraft selected Rolls-Royce's SMR design for three units on the west coast, marking the country's first new nuclear plant in over 40 years.
•Rolls-Royce, the UK National Nuclear Laboratory, and Japan’s JAEA signed memorandums to accelerate High-Temperature Gas-Cooled Reactor (HTGR) technology.
•Elicio Therapeutics reported complete radiographic and metabolic responses in metastatic pancreatic cancer patients treated with ELI-002 7P followed by checkpoint inhibition.
•UniQure announced that the U.S. FDA agreed that mid-stage study data could support an accelerated approval filing for its Huntington's disease gene therapy.
•NextEra Energy agreed to pay $150 million to settle a shareholder lawsuit alleging the company lied about its involvement in political interference schemes in Florida.
